The most recent lawsuit is from winter 2024, when the California attorney general announced a $5 million settlement with ...
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide launch of its pTau-217/Beta Amyloid 42 Ratio, a powerful new blood-based ...
Hosted on MSN11mon
Labcorp's (LH) Strategic Alliances Aid Amid Macroeconomic WoesThe Labcorp Plasma Focus test significantly advanced the company ... in innovation and technology that supports diagnostic and drug development testing for various diseases such as cancer ...
The antiviral drug remdesivir received emergency ... for a commercial RT-PCR diagnostic test was granted two weeks later to Labcorp. Serial enhancements, including automation and conversion ...
Hosted on MSN8d
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The PackHowever, headwinds such as reimbursement uncertainties, competition from decentralized testing solutions, and regulatory ...
With over 600 million tests performed annually and involvement in 90% of FDA-approved drugs in 2023, Labcorp (NYSE:LH) provides laboratory testing services and drug development solutions to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback